↓ Skip to main content

Dove Medical Press

Article Metrics

Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine

Overview of attention for article published in Neuropsychiatric Disease and Treatment, April 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (80th percentile)
  • High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter
5 tweeters
patent
2 patents
facebook
1 Facebook page
wikipedia
1 Wikipedia page

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
91 Mendeley
Title
Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
Published in
Neuropsychiatric Disease and Treatment, April 2016
DOI 10.2147/ndt.s80881
Pubmed ID
Authors

Anna I. Guerdjikova, Nicole Mori, Leah S. Casuto, Susan L. McElroy

Abstract

Binge eating disorder (BED) is the most common eating disorder and an important public health problem. It is characterized by recurrent episodes of excessive food consumption accompanied by a sense of loss of control over the binge eating behavior without the inappropriate compensatory weight loss behaviors of bulimia nervosa. BED affects both sexes and all age groups and is associated with medical and psychiatric comorbidities. Until recently, self-help and psychotherapy were the primary treatment options for patients with BED. In early 2015, lisdexamfetamine dimesylate, a prodrug stimulant marketed for attention deficit hyperactive disorder, was the first pharmacologic agent to be approved by the US Food and Drug Administration for the treatment of moderate or severe BED in adults. This article summarizes BED clinical presentation, and discusses the pharmacokinetic profile, efficacy, and safety of lisdexamfetamine dimesylate in the treatment of BED in adults.

Twitter Demographics

The data shown below were collected from the profiles of 5 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 91 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 91 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 16 18%
Researcher 13 14%
Student > Master 11 12%
Other 10 11%
Student > Postgraduate 6 7%
Other 15 16%
Unknown 20 22%
Readers by discipline Count As %
Medicine and Dentistry 22 24%
Psychology 14 15%
Neuroscience 5 5%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Social Sciences 4 4%
Other 15 16%
Unknown 26 29%

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 March 2021.
All research outputs
#2,838,127
of 17,994,434 outputs
Outputs from Neuropsychiatric Disease and Treatment
#409
of 2,705 outputs
Outputs of similar age
#51,581
of 271,481 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#13
of 84 outputs
Altmetric has tracked 17,994,434 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,705 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 271,481 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 80% of its contemporaries.
We're also able to compare this research output to 84 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.